Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
5.89 Down 0.29(4.74%) 3:59PM EDT
|After Hours : 5.92 Up 0.03 (0.51%) 7:50PM EDT
Prev Close:6.18
Open:6.16
Bid:5.90 x 900
Ask:5.92 x 15700
1y Target Est:9.34
Beta:1.22
Next Earnings Date: 6-Aug-14ARIA Earnings announcement
Day's Range:5.82 - 6.16
52wk Range:2.15 - 23.00
Volume:10,835,423
Avg Vol (3m):8,657,700
Market Cap:1.10B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIADown 4.74%1.10B
NVSDown 0.81%214.50B
PFEDown 0.49%192.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.04
Quarterly EPS Est (Jun-14) :-0.29
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback